Experienced in Brain Tumor

Martin Stuschke

Hufeland Str. 55, 
Essen, NW, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Brain Tumor
Hufeland Str. 55, 
Essen, NW, DE 
OverviewLocationsClinical Research

Overview

Martin Stuschke practices in Essen, Germany. Mr. Stuschke is rated as an Experienced expert by MediFind in the treatment of Brain Tumor. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Vitrectomy, and Endoscopy.

His clinical research consists of co-authoring 241 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 18 articles in the study of Brain Tumor.

Gender
Male

Locations

Hufeland Str. 55, Essen, NW 45147, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head and Neck Squamous Cell Carcinomas: A Phase I Study to Reduce Late Toxicity
De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head and Neck Squamous Cell Carcinomas: A Phase I Study to Reduce Late Toxicity
Enrollment Status: Recruiting
Publish Date: September 22, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
An Open Label, Phase Ia/Ib Trial of the DNA-PK Inhibitor MSC2490484A in Combination With Radiotherapy in Patients With Advanced Solid Tumors
An Open Label, Phase Ia/Ib Trial of the DNA-PK Inhibitor MSC2490484A in Combination With Radiotherapy in Patients With Advanced Solid Tumors
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Drug, Radiation
Study Phase: Phase 1
Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma.
Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma.
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2024
Intervention Type: Radiation, Drug
Study Drugs: Durvalumab, 5-Fluorouracil, Mitomycin C
Study Phase: Phase 2
Observational Study on Biomarkers in Head and Neck Cancer
Observational Study on Biomarkers in Head and Neck Cancer
Enrollment Status: Completed
Publish Date: August 03, 2022
Intervention Type: Biological
View 3 Less Clinical Trials

241 Total Publications

Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratification.
Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratification.
Journal: NPJ digital medicine
Published: August 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Stuschke's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 39 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile